Kidney cleanse? experimental drug aims to flush cholesterol from damaged kidneys
NCT ID NCT06489340
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial planned to test an experimental drug called VAR200 (2-HPβCD) in adults with type 2 diabetes and kidney disease. The drug works by removing extra cholesterol from kidney cells, which might help protect the kidneys. However, the study was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
2-hydroxypropyl-β-cyclodextrin (2-HPβCD)
What this could lead to
If it worked, this could point toward a new way to slow kidney damage in people with type 2 diabetes.
What could go wrong
The trial was withdrawn before enrolling anyone, so no results exist. It is very early-stage and may not be safe or effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Advancement Center, PLLC
San Antonio, Texas, 78212, United States